Lumos Pharma, Inc.

NASDAQ
LUMO
Stock
Yield per half year: +0.9302%
Dividend yield: 0%
Sector: Healthcare

Share chart Lumos Pharma, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Lumos Pharma, Inc.

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2011-11-11
ISIN US55028X1090
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 4.34
Change price per day: 0% (4.34)
Change price per week: 0% (4.34)
Change price per month: 0% (4.34)
Change price per 3 month: 0% (4.34)
Change price per half year: +0.9302% (4.3)
Change price per year: +87.88% (2.31)
Change price per 3 year: -43.56% (7.69)
Change price per 5 year: -51.78% (9)
Change price per 10 year: -89.7% (42.13)
Change price per year to date: 0% (4.34)
All parameters

Grade

Underestimation
Title Value Grade
P/S 12.07 1
P/BV 0.9068 9
P/E 0 0
EV/EBITDA 0.102 10
Total: 5
Efficiency
Title Value Grade
ROA, % -83.75 0
ROE, % -124.64 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.0557
Debt
Title Value Grade
Debt/EBITDA -0.1801 10
Total: 9.8
Growth impulse
Title Value Grade
Yield Revenue, % 119.12 10
Yield Ebitda, % -14.76 0
Yield EPS, % -87.34 0
Total: 2.2
More

Main owners

Institutions Volume Share, %
Wells Fargo & Company 417 051 5.14
Goldman Sachs Group Inc 406 611 5.02
Blackstone Inc 326 552 4.03
Vanguard Group Inc 244 082 3.01
Renaissance Technologies, LLC 221 614 2.73
Acuitas Investments LLC 125 282 1.55
Jefferies Financial Group Inc. 120 651 1.49
Lion Point Capital, LP 90 794 1.12
Greenwich Wealth Management LLC 76 341 0.94
Bridgeway Capital Management, Inc. 47 643 0.59

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Mr. Richard J. Hawkins Founder, CEO & Chairman 854.35k 1949 (76 years)
Dr. John C. McKew Ph.D. Chief Scientific Officer & President 860.38k 1964 (61 year)
Ms. Lori D. Lawley CPA CFO & Principal Accounting Officer 538.23k 1984 (41 year)
Mr. Bradley J. Powers J.D. Chief Compliance Officer & General Counsel 677.08k 1979 (46 years)
Mr. Aaron Schuchart B.B.A., CPA, M.B.A. Chief Business Officer N/A 1966 (59 years)
Dr. Pisit Pitukcheewanont FAAP, M.D. Chief Medical Officer N/A
Mr. Eddie L. Varnado M.B.A. Corporate Controller N/A
Ms. Lisa Wells Miller Senior Director of Investor Relations N/A
Ms. Alpa Parikh Senior Vice President of CMC & Supply Management

About company

Address: United States, Austin. TX, 4200 Marathon Boulevard - Open in google maps, Open in yandex maps
Website: https://lumos-pharma.com